Stay updated on MBG453 Combo with Azacitidine & Venetoclax Clinical Trial

Sign up to get notified when there's something new on the MBG453 Combo with Azacitidine & Venetoclax Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MBG453 Combo with Azacitidine & Venetoclax Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:55:24.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The date on the webpage has been updated from April 11, 2025, to April 18, 2025.
    Difference
    0.3%
    Check dated 2025-04-23T08:29:38.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The program has been terminated due to negative results from two trials, including the main trial, and the revision has been updated to v2.15.0.
    Difference
    6%
    Check dated 2025-04-16T02:07:40.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 19, 2025.
    Difference
    0.7%
    Check dated 2025-04-08T23:46:12.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The date on the webpage has been updated from March 5, 2025, to March 19, 2025.
    Difference
    0.3%
    Check dated 2025-03-25T13:16:36.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The date has been updated from March 3, 2025, to March 5, 2025.
    Difference
    0.3%
    Check dated 2025-03-10T23:57:29.000Z thumbnail image

Stay in the know with updates to MBG453 Combo with Azacitidine & Venetoclax Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MBG453 Combo with Azacitidine & Venetoclax Clinical Trial page.